POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management

POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management

GUANGZHOU, China, March 13, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade centered on the core track...

2ND ANNUAL CHICAGO RIVER SWIM RETURNS SEPT. 20 FOLLOWING HISTORIC FIRST YEAR, ESTABLISHING NEW CIVIC TRADITION

2ND ANNUAL CHICAGO RIVER SWIM RETURNS SEPT. 20 FOLLOWING HISTORIC FIRST YEAR, ESTABLISHING NEW CIVIC TRADITION

Presented by the City of Chicago and Mayor Brandon Johnson, the Swim celebrates the river's revival while supporting ALS research and youth swim education WHAT: Open-water swim through the Chicago River featuring hundreds of qualified swimmers...

Shrewsbury International School Hong Kong Launches Key Stage 3, Establishing Seamless Pathways to Global Excellence

Shrewsbury International School Hong Kong Launches Key Stage 3, Establishing Seamless Pathways to Global Excellence

HONG KONG, March 2, 2026 /PRNewswire/ -- Shrewsbury International School Hong Kong is pleased to announce the launch of its Key Stage 3 programme, welcoming Year 7 students starting August 2026, with Year 8 to follow in August 2027. This strategic...

MIRATECH Completes Acquisition of Exhaust Control Industries, Establishing a Strong APAC Operating Platform

MIRATECH Completes Acquisition of Exhaust Control Industries, Establishing a Strong APAC Operating Platform

Transaction strengthens global platform and accelerates regional delivery across rapidly expanding Asia Pacific markets TULSA, Okla., Feb. 25, 2026 /PRNewswire/ -- MIRATECH, a global authority in emissions and acoustic control solutions for...

CTK Launches Dedicated OTC Facility in California, Establishing a Strategic Hub for Global K-beauty Expansion

CTK Launches Dedicated OTC Facility in California, Establishing a Strategic Hub for Global K-beauty Expansion

SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- CTK(KOSDAQ: 260930), a global K-beauty original design manufacturer (ODM) for cosmetics, has begun operations at CTK OTC LABORATORIES (COL), its new dedicated over-the-counter (OTC) manufacturing...

TEIZA Initiates The Malaysian Blockchain Consortium with 19 Strategic Partners Through Historic MOU Signing Ceremony

TEIZA Initiates The Malaysian Blockchain Consortium with 19 Strategic Partners Through Historic MOU Signing Ceremony

KUALA LUMPUR, Malaysia, Nov. 26, 2025 /PRNewswire/ -- TEIZA, a blockchain company invested in by the Finran Group, announced the formation of the Malaysia Blockchain Consortium, marking a pivotal milestone in the nation's digital transformation...

Metis Global Group Sets New Regional Benchmark with Sixth Bloomberg Award

Metis Global Group Sets New Regional Benchmark with Sixth Bloomberg Award

HONG KONG, June 25, 2025 /PRNewswire/ -- Metis Global Group (Metis) has once again been recognised for its exceptional trust services and outstanding performance, receiving the "Excellence Award of Trustee Service" for the sixth time from the...

SK chemicals Partners with Ministry of the Interior and Safety and Local Governments to Create a Leading Waste Banner Recycling Model

SK chemicals Partners with Ministry of the Interior and Safety and Local Governments to Create a Leading Waste Banner Recycling Model

"Establishing a Complete Circular System for Waste Banners Through Public-Private Collaboration" Signing of MOU on Waste Banner Recycling for Regional and Corporate Co-Prosperity Led by the Ministry of the Interior and Safety, with Participation...

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2026. Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding...

menu
menu